Publications by authors named "Owen Lockerbie"

Claim this Profile
I
Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft model.
Teresa Troiani, Natalie J Serkova, Daniel L Gustafson, Thomas K Henthorn, Owen Lockerbie

Clin Cancer Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases.
Teresa Troiani, Owen Lockerbie, Mark Morrow, Fortunato Ciardiello, S Gail Eckhardt

Mol Cancer Ther· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.
Junzhi Li, Owen Lockerbie, Dirk de Korte, Joe Rice, Robyn McLean

Transfusion· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.
Vijay Kumar, Owen Lockerbie, Shawn D Keil, Patrick H Ruane, Matthew S Platz

Photochem Photobiol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis